Cipla (NSE:CIPLA) Construction In Progress: ₹19,430 Mil (As of Mar. 2026)


NSE:CIPLA Cipla Ltd NSE:CIPLA
94 GF Score
Price ₹1,440.10
GF Value ₹1,566.43
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cipla Construction In Progress?

Cipla NSE:CIPLA +0.15% 94 Construction In Progress is ₹19,430 Mil as of Mar. 2026. GuruFocus rates NSE:CIPLA with a GF Score™ of 94/100 and a GF Value™ of ₹1,566.43 (Fairly Valued). The stock has 5 warning signs investors should review.

Cipla's quarterly construction in progress declined from Sep. 2025 (₹14,367 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹19,430 Mil).

Cipla's annual construction in progress increased from Mar. 2024 (₹11,021 Mil) to Mar. 2025 (₹14,432 Mil) and increased from Mar. 2025 (₹14,432 Mil) to Mar. 2026 (₹19,430 Mil).

Cipla Construction In Progress Historical Data

* Premium members only.

The historical data trend for Cipla's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipla Construction In Progress Chart

Cipla Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,370.70 8,918.40 11,021.40 14,431.90 19,429.70

Cipla Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,431.90 0.00 14,367.00 0.00 19,429.70
NSE:CIPLA
94GF Score
Cipla Ltd NSE:CIPLA
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cipla Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹19,430 Mil mean?
Cipla (NSE:CIPLA) has a Construction In Progress of ₹19,430 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Cipla and its competitors.
Is Cipla's Construction In Progress too high?
Cipla's current Construction In Progress is ₹19,430 Mil. Overall, Cipla has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cipla's Construction In Progress compare to ZTS and UTHR?
Cipla's Construction In Progress of ₹19,430 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Cipla and its competitors. Cipla's current Construction In Progress is ₹19,430 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipla stock overvalued right now?
Based on GuruFocus' analysis, Cipla (NSE:CIPLA) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,566.43, compared to a current price of ₹1,440.10 — trading 8.1% below its estimated fair value. The current Construction In Progress is ₹19,430 Mil. Cipla's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Cipla (NSE:CIPLA), the current Construction In Progress is ₹19,430 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cipla (NSE:CIPLA) Overvalued in 2026?

Based on GuruFocus' analysis, Cipla stock appears to be undervalued. The current stock price of ₹1,440.10 is trading 8.1% below its estimated GF Value™ of ₹1,566.43. GuruFocus considers Cipla to be Fairly Valued.

Key valuation signals for NSE:CIPLA:

  • Construction In Progress: ₹19,430 Mil
  • GF Value™: ₹1,566.43 vs. price of ₹1,440.10 (8.1% below fair value)
  • GF Score™: 94/100 with 5 warning signs

No single metric tells the full story. See the NSE:CIPLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cipla Business Description

Other Exchanges 500087:India
Address Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.
94GF Score

Get the complete analysis for NSE:CIPLA

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,440.10
Price
₹1,566.43
GF Value